Biocure Technology Inc.
BICTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $1,476 |
| G&A Expenses | $309 | $301 | $636 | $2,342 |
| SG&A Expenses | $318 | $1,052 | $674 | $1,425 |
| Sales & Mktg Exp. | $9 | $751 | $38 | -$917 |
| Other Operating Expenses | $0 | $0 | $0 | -$1,167 |
| Operating Expenses | $318 | $1,052 | $674 | $1,735 |
| Operating Income | -$318 | -$1,052 | -$674 | -$1,735 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $56 | -$442 | $270 | -$797 |
| Pre-Tax Income | -$262 | -$1,494 | -$403 | -$2,532 |
| Tax Expense | $0 | $0 | $0 | -$663 |
| Net Income | -$262 | -$1,814 | -$1,450 | -$1,128 |
| % Margin | – | – | – | – |
| EPS | -0.025 | -0.013 | -0.003 | -0.01 |
| % Growth | -96.1% | -300% | 68% | – |
| EPS Diluted | -0.025 | -0.016 | -0.003 | -0.01 |
| Weighted Avg Shares Out | 10,444 | 114,799 | 106,932 | 103,039 |
| Weighted Avg Shares Out Dil | 10,444 | 92,861 | 106,917 | 103,039 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $88 |
| Interest Expense | $0 | $0 | $0 | $49 |
| Depreciation & Amortization | $318 | $1,052 | $6 | $64 |
| EBITDA | $0 | $0 | -$668 | -$1,671 |
| % Margin | – | – | – | – |